Kiin Bio Closes €1.9M in Funding to Launch AI-Powered Virtual Scientist Platform for Drug Discovery

Kiin Bio, a British life sciences startup, has closed an oversubscribed €1.9 million pre-seed round to launch KiinOS, its AI-native Virtual Scientist Platform aimed at transforming drug discovery. The round was led by b2venture, with support from Heartfelt, rule30, and strategic angels.

CEO and co-founder Filippo Abbondanza said that the future of drug discovery lies in smart integration and the company’s platform turns fragmented tools into a unified engine for breakthroughs.

Built to streamline tasks from literature review to wet-lab execution, KiinOS combines agentic AI, bioinformatics, and scalable infrastructure. Already in pilot with partners via its Frontier Programme, Kiin Bio plans to expand its platform and team, with a community edition coming later this year.

Featured image: Credit: Kiin Bio

Need Deeper Intelligence on the AI Market?

AI Insider's Market Intelligence platform tracks funding rounds, competitive landscapes, and technology trends across the global AI ecosystem in real time. Get the data and insights your organization needs to make informed decisions.

Explore Market Intelligence

Related Articles

Karias Health Launches Faith, an AI Care Companion Built for Real-Time Healthcare Decisions

Insider Brief Leaving a doctor’s appointment without a clear understanding of the diagnosis, treatment plan or next steps isn’t unusual for patients. To help cut

Mayo Clinic Study Shows AI Can Reveal Brain Tumor Risks Without Costly Genetic Testing

Insider Brief Researchers at Mayo Clinic have developed an artificial intelligence system that can analyze routine pathology slides and predict the likelihood that the tumors

Neura Robotics Announces $1.4B Series C Including Nvidia, Amazon, Tether and Qualcomm

Insider Brief Neura Robotics has secured a Series C funding round of up to $1.4 billion as the German robotics company looks to expand deployment

Stay Updated with AI Insider

Get the latest AI funding news, market intelligence, and industry insights delivered to your inbox weekly.

Subscribe on LinkedIn
  • Explore Our Solutions

Market Intelligence & Data

Track funding, map landscapes, and access bespoke data cuts.

Strategic Advisory

Market entry playbooks, ecosystem analysis, and technology scouting.

Due Diligence

Technical, commercial, and regulatory assessments for investors.

  • Resonance Data Spotlight
$ 0 M

Seed round tracked

Gitar — Code Validation

View full funding dataset
  • Related Intelligence

Karias Health Launches Faith, an AI Care Companion Built for Real-Time Healthcare Decisions

Mayo Clinic Study Shows AI Can Reveal Brain Tumor Risks Without Costly Genetic Testing

Neura Robotics Announces $1.4B Series C Including Nvidia, Amazon, Tether and Qualcomm

  • Insider Brief

Get the Weekly Briefing

Funding analysis, market intelligence, and industry trends delivered to your inbox every week.

Subscribe on LinkedIn
Need bespoke intelligence?

Our team combines real-time data with decades of sector experience to guide your decisions.

Get in Touch

Subscribe today for the latest news about the AI landscape

SUBSCRIBE